🚨 BREAKTHROUGH: Scientists Develop Sugar-Coated Nanoparticle That Blocks COVID-19 Virus From Binding to Human Cells Reduces Infection by ~99% in Lab Experiments
www.news-medical.net/news/2025081...
www.news-medical.net/news/2025081...
Synthetic sugar-coated nanoparticle blocks Covid-19 from infecting human cells
Groundbreaking research led by a Swansea University academic has revealed a synthetic glycosystem - a sugar-coated polymer nanoparticle - that can block Covid-19 from infecting human cells, reducing i...
www.news-medical.net
June 18, 2026 at 12:59 PM
🚨 BREAKTHROUGH: Scientists Develop Sugar-Coated Nanoparticle That Blocks COVID-19 Virus From Binding to Human Cells Reduces Infection by ~99% in Lab Experiments
www.news-medical.net/news/2025081...
www.news-medical.net/news/2025081...
This is a good one.
Synthetic sugar-coated nanoparticle blocks Covid-19 from infecting human cells
Groundbreaking research led by a Swansea University academic has revealed a synthetic glycosystem - a sugar-coated polymer nanoparticle - that can block Covid-19 from infecting human cells, reducing i...
www.news-medical.net
June 18, 2026 at 4:52 PM
This is a good one.
BREAKING: Scientists Develop Sugar-Coated Nanoparticle That Blocks COVID-19 Virus From Binding to Human Cells Reduces Infection by ~99% in Lab Experiments
August 14, 2025 at 1:43 PM
BREAKING: Scientists Develop Sugar-Coated Nanoparticle That Blocks COVID-19 Virus From Binding to Human Cells Reduces Infection by ~99% in Lab Experiments
GOOD NEWS! Researchers at the University of Buffalo have developed a nanoparticle-based vaccine candidate for H5N1 avian influenza (clade 2.3.4.4b) that achieved 100% PROTECTION in preclinical trials. The vaccine is under development for potential use in BOTH veterinary AND human medicine. 🧪🧵⬇️
April 22, 2025 at 4:00 PM
GOOD NEWS! Researchers at the University of Buffalo have developed a nanoparticle-based vaccine candidate for H5N1 avian influenza (clade 2.3.4.4b) that achieved 100% PROTECTION in preclinical trials. The vaccine is under development for potential use in BOTH veterinary AND human medicine. 🧪🧵⬇️
Big health breakthrough: a protein from tardigrades can now protect human cells from radiation.
That’s going to lead to better cancer therapies.
That’s going to lead to better cancer therapies.
Radioprotection of healthy tissue via nanoparticle-delivered mRNA encoding for a damage-suppressor protein found in tardigrades - Nature Biomedical Engineering
Radiation-therapy-induced DNA damage in oral and rectal epithelial cells can be reduced via the nanoparticle-mediated local delivery of messenger RNA encoding for a damage-suppressor protein found in ...
www.nature.com
March 5, 2025 at 8:58 PM
Big health breakthrough: a protein from tardigrades can now protect human cells from radiation.
That’s going to lead to better cancer therapies.
That’s going to lead to better cancer therapies.
"Sugar coated nanoparticle" just makes me think vaccination via pixie stix
August 12, 2025 at 4:22 PM
"Sugar coated nanoparticle" just makes me think vaccination via pixie stix
Do we have even one nanoparticle of hard evidence that DOGE has found even one dollar of actual waste, fraud, or abuse?
March 29, 2025 at 1:34 AM
Do we have even one nanoparticle of hard evidence that DOGE has found even one dollar of actual waste, fraud, or abuse?
GOOD NEWS! Researchers have revealed a synthetic glycosystem -a sugar-coated polymer nanoparticle- that can BLOCK SARS-CoV-2 from infecting human cells, REDUCING infection rates by NEARLY 99%. Acting as a decoy, the molecule BINDS to the spike protein, PREVENTING it from attaching to real cells.
August 12, 2025 at 4:00 PM
GOOD NEWS! Researchers have revealed a synthetic glycosystem -a sugar-coated polymer nanoparticle- that can BLOCK SARS-CoV-2 from infecting human cells, REDUCING infection rates by NEARLY 99%. Acting as a decoy, the molecule BINDS to the spike protein, PREVENTING it from attaching to real cells.
NEW: Scientists made a sugar-coated nanoparticle that blocks the SARS-CoV-2 virus from binding to human cells — cutting infection in lab tests by ~99%.
Not a vaccine. A microscopic shield. 🛡️🦠 www.news-medical.net/news/2025081...
#BlueSky #MedSky 🧪 #IDSky #SciSky#fmsky #pedsky
Not a vaccine. A microscopic shield. 🛡️🦠 www.news-medical.net/news/2025081...
#BlueSky #MedSky 🧪 #IDSky #SciSky#fmsky #pedsky
Synthetic sugar-coated nanoparticle blocks Covid-19 from infecting human cells
Groundbreaking research led by a Swansea University academic has revealed a synthetic glycosystem - a sugar-coated polymer nanoparticle - that can block Covid-19 from infecting human cells, reducing i...
www.news-medical.net
August 13, 2025 at 1:45 AM
NEW: Scientists made a sugar-coated nanoparticle that blocks the SARS-CoV-2 virus from binding to human cells — cutting infection in lab tests by ~99%.
Not a vaccine. A microscopic shield. 🛡️🦠 www.news-medical.net/news/2025081...
#BlueSky #MedSky 🧪 #IDSky #SciSky#fmsky #pedsky
Not a vaccine. A microscopic shield. 🛡️🦠 www.news-medical.net/news/2025081...
#BlueSky #MedSky 🧪 #IDSky #SciSky#fmsky #pedsky
Machine learning (ML) is being explored in for nanoparticle-based drug delivery systems. A Review in Nature Reviews Bioengineering discusses how ML can predict nanoparticle properties, identify optimal formulations, discover new excipients and forecast biological and therapeutic outcomes. 🔒
Artificial intelligence and machine learning in nanoparticle drug delivery systems - Nature Reviews Bioengineering
Artificial intelligence (AI) and, in particular, machine learning (ML) are being explored in the development of nanoparticle-based drug delivery systems, from formulation design to preclinical evaluation. This Review discusses how ML can predict nanoparticle properties, identify optimal formulations, discover new excipients and forecast biological and therapeutic outcomes by integrating complex datasets.
go.nature.com
September 26, 2026 at 7:02 PM
Machine learning (ML) is being explored in for nanoparticle-based drug delivery systems. A Review in Nature Reviews Bioengineering discusses how ML can predict nanoparticle properties, identify optimal formulations, discover new excipients and forecast biological and therapeutic outcomes. 🔒
WOAH:
"Research led by a Swansea University academic has revealed a synthetic glycosystem - a sugar-coated polymer nanoparticle - that can block Covid-19 from infecting human cells, reducing infection rates by nearly 99%."
www.news-medical.net/news/2025081... (via @covid19disease.bsky.social)
"Research led by a Swansea University academic has revealed a synthetic glycosystem - a sugar-coated polymer nanoparticle - that can block Covid-19 from infecting human cells, reducing infection rates by nearly 99%."
www.news-medical.net/news/2025081... (via @covid19disease.bsky.social)
Synthetic sugar-coated nanoparticle blocks Covid-19 from infecting human cells
Groundbreaking research led by a Swansea University academic has revealed a synthetic glycosystem - a sugar-coated polymer nanoparticle - that can block Covid-19 from infecting human cells, reducing i...
www.news-medical.net
August 14, 2025 at 4:23 PM
WOAH:
"Research led by a Swansea University academic has revealed a synthetic glycosystem - a sugar-coated polymer nanoparticle - that can block Covid-19 from infecting human cells, reducing infection rates by nearly 99%."
www.news-medical.net/news/2025081... (via @covid19disease.bsky.social)
"Research led by a Swansea University academic has revealed a synthetic glycosystem - a sugar-coated polymer nanoparticle - that can block Covid-19 from infecting human cells, reducing infection rates by nearly 99%."
www.news-medical.net/news/2025081... (via @covid19disease.bsky.social)
We interrupt the rare cheerful political news to bring you some rare cheerful health news.
Researchers have developed a nanoparticle-based vaccine that prevented several kinds of cancers in mice, apparently very effectively.
www.umass.edu/news/article...
Researchers have developed a nanoparticle-based vaccine that prevented several kinds of cancers in mice, apparently very effectively.
www.umass.edu/news/article...
UMass Amherst Researchers Create Nanoparticle Vaccine That Prevents Cancer in Mice | UMass Amherst
The vaccine also proves highly effective at preventing cancer’s deadly spread.
www.umass.edu
November 5, 2025 at 5:32 PM
We interrupt the rare cheerful political news to bring you some rare cheerful health news.
Researchers have developed a nanoparticle-based vaccine that prevented several kinds of cancers in mice, apparently very effectively.
www.umass.edu/news/article...
Researchers have developed a nanoparticle-based vaccine that prevented several kinds of cancers in mice, apparently very effectively.
www.umass.edu/news/article...
Scientists have developed a unique nanoparticle vaccine that prevented the development of multiple forms of cancer in mice.
🔗 www.404media.co/a-new-nanopa...
🔗 www.404media.co/a-new-nanopa...
A New 'Nanoparticle Vaccine' Prevented Cancer In Mice, Study Says
The vast majority of mice that received the vaccine warded off repeated exposure to cancer cells, but the applications for humans are still not known.
www.404media.co
October 9, 2025 at 3:10 PM
Scientists have developed a unique nanoparticle vaccine that prevented the development of multiple forms of cancer in mice.
🔗 www.404media.co/a-new-nanopa...
🔗 www.404media.co/a-new-nanopa...
Scientists Develop Sugar-Coated Nanoparticle That Blocks COVID-19 Virus From Binding to Human Cells Reduces Infection by ~99% in Lab Experiments
January 21, 2026 at 4:55 PM
Scientists Develop Sugar-Coated Nanoparticle That Blocks COVID-19 Virus From Binding to Human Cells Reduces Infection by ~99% in Lab Experiments
Lipid nanoparticle-mediated mRNA delivery to CD34+ cells in rhesus monkeys go.nature.com/3CGO1Dy
Lipid nanoparticle-mediated mRNA delivery to CD34+ cells in rhesus monkeys - Nature Biotechnology
A lipid nanoparticle is used to deliver mRNA to hematopoietic stem cells in macaques.
go.nature.com
November 22, 2024 at 5:07 PM
Lipid nanoparticle-mediated mRNA delivery to CD34+ cells in rhesus monkeys go.nature.com/3CGO1Dy
🧠✨ New nanoparticle therapy reverses Parkinson’s in mice
A wireless deep brain stimulation system has been developed that uses gold nanoparticles & light to clear harmful proteins & restore dopamine neurons, improving motor function.
🔗 www.science.org/doi/10.1126/...
#Parkinsons #SciComm 🧪 🧬
A wireless deep brain stimulation system has been developed that uses gold nanoparticles & light to clear harmful proteins & restore dopamine neurons, improving motor function.
🔗 www.science.org/doi/10.1126/...
#Parkinsons #SciComm 🧪 🧬
A nanoparticle-based wireless deep brain stimulation system that reverses Parkinson’s disease
Nanoparticle-mediated wireless system reverses Parkinson’s disease.
www.science.org
January 17, 2025 at 7:23 PM
🧠✨ New nanoparticle therapy reverses Parkinson’s in mice
A wireless deep brain stimulation system has been developed that uses gold nanoparticles & light to clear harmful proteins & restore dopamine neurons, improving motor function.
🔗 www.science.org/doi/10.1126/...
#Parkinsons #SciComm 🧪 🧬
A wireless deep brain stimulation system has been developed that uses gold nanoparticles & light to clear harmful proteins & restore dopamine neurons, improving motor function.
🔗 www.science.org/doi/10.1126/...
#Parkinsons #SciComm 🧪 🧬
Ants must be the best friends because one finds a nanoparticle of cake on the counter and says “I’m gonna call my 500 best homies, they gotta try this shit”
July 15, 2026 at 1:04 PM
Ants must be the best friends because one finds a nanoparticle of cake on the counter and says “I’m gonna call my 500 best homies, they gotta try this shit”
Well done to @swanseauni.bsky.social for this brilliant discovery! www.news-medical.net/news/2025081...
Synthetic sugar-coated nanoparticle blocks Covid-19 from infecting human cells
Groundbreaking research led by a Swansea University academic has revealed a synthetic glycosystem - a sugar-coated polymer nanoparticle - that can block Covid-19 from infecting human cells, reducing i...
www.news-medical.net
August 13, 2025 at 10:56 AM
Well done to @swanseauni.bsky.social for this brilliant discovery! www.news-medical.net/news/2025081...
An mRNA-LNP vaccine for cryptococcus neoformans effective in a murine model. Cryptococcus is one of the highest burden fungal diseases which can cause severe infection especially in the immunocompromised 🧪 #idsky @germhuntermd.bsky.social
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model - npj Vaccines
npj Vaccines - Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model
www.nature.com
February 5, 2025 at 1:04 PM
An mRNA-LNP vaccine for cryptococcus neoformans effective in a murine model. Cryptococcus is one of the highest burden fungal diseases which can cause severe infection especially in the immunocompromised 🧪 #idsky @germhuntermd.bsky.social
www.nature.com/articles/s41...
www.nature.com/articles/s41...
The mRNA/nanoparticle platform has saved over 20 million lives during Covid, is being used to treat cancer, rare diseases (via genome editing) and autoimmune diseases, no less many other infectious diseases w/o a vaccine. Now it's under siege.
A1, NYT
gift link www.nytimes.com/2025/05/08/u...
A1, NYT
gift link www.nytimes.com/2025/05/08/u...
May 12, 2025 at 1:58 PM
The mRNA/nanoparticle platform has saved over 20 million lives during Covid, is being used to treat cancer, rare diseases (via genome editing) and autoimmune diseases, no less many other infectious diseases w/o a vaccine. Now it's under siege.
A1, NYT
gift link www.nytimes.com/2025/05/08/u...
A1, NYT
gift link www.nytimes.com/2025/05/08/u...
Reference
Rossi, M., Bianchi, L., & Ferrero, G. (2026). Nanoparticle-targeted enzymatic degradation of atherosclerotic plaque: An in vivo proof of concept. European Heart Journal, 47(18), 1422-1435. Published in European Heart Journal
Rossi, M., Bianchi, L., & Ferrero, G. (2026). Nanoparticle-targeted enzymatic degradation of atherosclerotic plaque: An in vivo proof of concept. European Heart Journal, 47(18), 1422-1435. Published in European Heart Journal
June 1, 2026 at 7:47 PM
Reference
Rossi, M., Bianchi, L., & Ferrero, G. (2026). Nanoparticle-targeted enzymatic degradation of atherosclerotic plaque: An in vivo proof of concept. European Heart Journal, 47(18), 1422-1435. Published in European Heart Journal
Rossi, M., Bianchi, L., & Ferrero, G. (2026). Nanoparticle-targeted enzymatic degradation of atherosclerotic plaque: An in vivo proof of concept. European Heart Journal, 47(18), 1422-1435. Published in European Heart Journal
Major advance for refractory lupus by engineering the T cells in the patient's body (in vivo) and achieving success in 5 patients @nejm.org (uses mRNA/nanoparticle package)
www.nejm.org/doi/full/10....
www.nejm.org/doi/full/10....
September 17, 2025 at 9:33 PM
Major advance for refractory lupus by engineering the T cells in the patient's body (in vivo) and achieving success in 5 patients @nejm.org (uses mRNA/nanoparticle package)
www.nejm.org/doi/full/10....
www.nejm.org/doi/full/10....